Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Novartis curates interactive history of medicine exhibition

Beautiful Medicine highlights nature's role in the past and future ofdevelopment

Novartis digital exhibition

Novartis has launched an interactive exhibition that showcases the role played by nature in the history of medicine.

Beautiful Medicine is a slick 'digital exhibition' that highlights the way natural substances have been used in medicines development and what the future could hold for this area of research.

For example, Novartis is currently cataloguing and experimenting with approximately 15,000 natural products as part of its efforts to screen their responses when added to diseased cells.

These responses are then examined the biological target of the natural compound as part of work to see which cellular protein it binds to and therefore which protein most likely plays a role in the disease.

Novartis is one of the few big pharmaceutical companies still involved in 'bioprospection' - developing new products based on existing biological resources. In pursuit of possible treatments for narcolepsy the Novartis Institutes for BioMedical Research has identified a class of compounds that temporarily blocks a receptor involved with regulating wakefulness - the starting point for which was its work on ergoline alkaloids, a class of natural products synthesized by fungi.

Another firm active in this space is Pharma Mar, whose marine-derived antitumoral agent Yondelis (trabectedin) received US approval last month to treat unresectable or metastic liposarcoma or leiomyosarcoma.

10th November 2015

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics